Prediction of antiviral therapy response
AssigneesResearch Corporation, Novartis Florschungsstiftung, Zweigniederlassung friedrich Mischer Institute for Biomedical
InventorsWitold Filipowicz, Markus Heim, Magdalena Filipowicz, Jacek Krol, Ilona Markiewicz
Life of this patent
Estimating the term…
Abstract
The application relates to methods for determining whether or not antiviral therapies will be effective. In particular, the present application provides a method using miRNA, e.g. miR-122 or miR-296-5p, for determining the likelihood that a subject having a viral infection of the liver will be responsive to antiviral therapy that includes stimulation of Interferon (IFN) activity, and kits for the performance of said determination.
Claims15
A method for determining the likelihood that a subject having a viral infection of the liver will be responsive to antiviral therapy that includes stimulation of Interferon (IFN) activity, the method comprising:
- (a) analysing a sample from the subject for the level of expression of a miRNA and,
- (b) comparing the level of expression of said miRNA in the sample from the subject to the levels of said miRNA in a control sample.
Dependencies are inferred from the claim text.